$14.53
-0.08-0.55%
Últ. Act.: Oct 23, 4:00 PM
Carlsmed (CARL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Carlsmed (CARL) publicó su última previsión de septiembre 28, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $74M - $78M para el período.
En comparación con la previsión anterior, Carlsmed mantenido redujo su previsión de ingresos desde un rango anterior de $74M - $78M.
Carlsmed ha emitido 8 actualizaciones de orientación entre el agosto 28, 2025 y el septiembre 28, 2026. During this period, the company raised its outlook 5 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.38 | $-0.40 | $-0.43 | $-0.47 |
| Actual | $-0.39 | $-0.32 | $-0.32 | $-0.40 |
| Surprise | -2.63% | +20.0% | +25.6% | +14.9% |
| Revenue | ||||
| Estimate | $18.1M | $14.9M | $14.9M | $11.5M |
| Actual | $18.9M | $16.1M | $15.2M | $13.1M |
| Surprise | +4.78% | +8.37% | +2.07% | +14.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.39 | $-0.35 | $-0.37 | $-0.39 |
| Revenue | ||||
| Consensus | $19.2M | $22.4M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.39 | $-0.38 | -2.63 % |
| Q1 | May 5, 2026 | $-0.32 | $-0.40 | 20.0 % |
| Q4 | Feb 25, 2026 | $-0.32 | $-0.43 | 25.6 % |
| Q3 | Nov 6, 2025 | $-0.40 | $-0.47 | 14.9 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $18.94M | $18.08M | 4.78 % |
| Q1 | May 5, 2026 | $16.10M | $14.86M | 8.37 % |
| Q4 | Feb 25, 2026 | $15.17M | $14.86M | 2.07 % |
| Q3 | Nov 6, 2025 | $13.07M | $11.46M | 14.1 % |